Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus

Phase 2TerminatedNCT00208936

Emory University20 enrolled

Overview

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Esophageal Diseases

Interventions

Taxol, Cisplatin, 5-Fluorouracil, G-CSFDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older. Exclusion Criteria: * Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Locations (1)

Emory University Winship Cancer Institute

Atlanta, Georgia, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.